GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
X

Xvivo Perfusion XVIVO.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

200.80

+1.67%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Xvivo Perfusion annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
RevenueSEK 812.2mSEK 822.4mSEK 597.5mSEK 415.3mSEK 258.4m
Operating incomeSEK 93.0mSEK 88.4mSEK 10.0mSEK 23.2mSEK 7.0m
Net incomeSEK 25.2mSEK 172.2mSEK 91.8mSEK 18.4mSEK 8.2m
Free cash flow—−SEK 81.9mSEK 3.3m−SEK 103.1m−SEK 106.1m
Total assetsSEK 2.37bnSEK 2.40bnSEK 2.20bnSEK 1.73bnSEK 1.54bn
Shareholders' equitySEK 2.11bnSEK 2.16bnSEK 1.95bnSEK 1.43bnSEK 1.29bn

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.